Sponsors (2)
The resolution raises awareness, newborn screening, research, and equity attention for sickle cell disease—potentially improving diagnosis, reducing child mortality, and advancing curative therapies—but it is nonbinding and provides no funding guarantee, leaving access to costly treatments and any taxpayer impacts unresolved.
Infants, children, and people with SCD/SCT (especially in affected communities) would benefit from an emphasis on newborn screening and increased awareness, leading to earlier diagnosis, faster linkage to care, and reduced childhood mortality.
People with SCD (particularly racial and ethnic minorities who bear disproportionate burden) could see expanded research focus and commitments to equitable access, which may accelerate availability of curative therapies (e.g., HSCT, approved gene therapies) over time.
State governments, hospitals, health systems, and affected communities may gain federal and international attention and coordination as SCD is elevated as a public health priority, encouraging program development to address long-standing disparities.
Taxpayers and the public should note the resolution is declaratory and nonbinding; it does not provide funding, so Americans may see no immediate expansion of services or programs without future appropriations.
People with SCD—particularly low-income individuals—may face limited access to highlighted curative and high-cost therapies because emphasis on these treatments could raise expectations that are not matched by coverage or affordability.
Taxpayers could face pressure for increased domestic or international spending to expand programs addressing the global burden of SCD, creating potential trade-offs with other budget priorities.
Based on analysis of 1 section of legislative text.
Recognizes the public health impact of sickle cell disease/trait, designates June 19, 2026 as World Sickle Cell Awareness Day, and urges screening, research, equitable access, and improved care.
Official title: Expressing support for the designation of June 19, 2026, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.
Introduced June 18, 2026 by Cory Anthony Booker · Last progress June 18, 2026
Recognizes sickle cell disease (SCD) and sickle cell trait (SCT) as serious inherited blood disorders that affect hundreds of thousands to millions of people in the United States, disproportionately impacting people of African descent. Designates June 19, 2026, as World Sickle Cell Awareness Day and calls for continued research, early newborn screening, equitable access to treatments and cures, prevention efforts, and improved care and support services.